ARTICLE | Financial News
Apricus proposes follow-on
March 31, 2017 7:34 PM UTC
Urology and rheumatology company Apricus Biosciences Inc. (NASDAQ:APRI) proposed to raise up to $6.9 million in a follow-on underwritten by H.C. Wainwright on March 30....
BCIQ Company Profiles